GMD’s 2QFY24 result was strong with production and sales 16% and 29% higher than we had expected. The release of the five-year strategy outlook in March that will outline the pathway to +300kozpa continues to overshadow near-term news flow. We believe the outlook has the potential to surprise on the upside and we reiterate our BUY rating and A$2.40 price target.
To access the full report please log in under the Client Area at the bottom of this page.
Argonaut’s Client Area allows you to view delayed share prices, access Argonaut’s wealth of Research as well as create custom portfolios and set up company watch lists.
If you would like to access our research please contact us to create an account.
